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We have previously demonstrated that challenge of rat or mice with lipopolysaccharide (LPS) in vivo promotes Sp1 protein degradation. The
protease responsible for the LPS-induced Sp1 degradation has not been identified. In this study, we have identified, characterized and partially
purified an LPS-inducible Sp1-degrading enzyme (LISPDE) activity from rat lungs. LISPDE activity selectively degraded Sp1, but not nuclear
protein, C-fos, p65, I-κBα and protein actin. Nuclear extract contains approximately 14-fold of the LISPDE activity as that detected in cytoplasmic
extract, suggesting that LISPDE is predominantly a nuclear protease. Using biochemical reagents, protease inhibitors and peptide substrates, we
have characterized the LISPDE activity. Based on biochemical characteristics, inhibitor profile, and substrate specificity, we have shown that
LISPDE activity is not 26S proteasome, caspase or cathepsin-like activity, but is a trypsin-like serine protease activity. Using soybean trypsin
inhibitor (SBTI)–sepharose affinity column, we have partially purified the LISPDE protein, which has an estimated molecular mass of 33 kDa and
selectively degrades native Sp1 protein. We mapped the initial site for proteolytic cleavage of Sp1 by LISPDE to be located within the region
between amino acids 181–328. We conclude that LPS causes Sp1 degradation by inducing a unique trypsin-like serine protease, LISPDE.
© 2006 Elsevier B.V. All rights reserved.Keywords: Protease; Sp1; Lipopolysaccharide; Transcription factor; Lung; Gene regulation1. Introduction
The transcription factor, specificity protein 1 (Sp1), belongs
to the Sp family of proteins consisting of at least 8 members
(Sp1–8) [1,2]. Sp1 is an extremely versatile transcription factor
and is involved in the transcription of very large number of
genes (for a complete list, refer to PubMed, using key word
sp1), particularly housekeeping genes and tissue-specific genes
[1–5]. Because gene transcription is an integral component ofAbbreviations: LPS, lipopolysaccharide; Sp1, promoter selective transcription
factor 1; LISPDE, LPS-inducible Sp1 degrading enzyme; LLnL, N-acetyl-L-
leucinyl-L-leucinyl-L-norleucinal; LTC, clasto-lactacystin-β-lactone; AMP-PNP,
5′-adenylylimino-diphosphate; TPCK, N-Tosyl-L-phenylalanine chloromethyl
ketone; SBTI, soybean trypsin inhibitor; E-64, trans-epoxysuccinyl-L-leucylamid
O-(4-guanidino) butane; ALLM, N-acetyl-Leu-Leu-Met-AL; AMC, 7-amino-4-
methylcoumarin
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doi:10.1016/j.bbamcr.2006.09.013many biological and physiological processes, alteration in Sp1
activity and/or protein abundance could play an important role
in the regulation of organ functions both under physiological
and pathophysiological conditions. Thus, elucidation of the
molecular mechanisms and signal transduction pathways that
regulate Sp1 activity, Sp1 protein abundance and turnover will
help us to better understand many physiological and pathophy-
siological processes.
Sp1 activities (binding and trans-activating) are regulated by
a variety of stimuli. Mechanisms involved in these regulations
include posttranslational modification (phosphorylation and
glycosylation), alteration in cellular Sp1 protein abundance
and interaction with other regulatory proteins. Sp1 protein is
phosphorylated by multiple kinases [5–11], and dephosphory-
lated by several phosphatases [5,10,12,13]. Depending on cell
types and stimuli, phosphorylation results in increased [7–10],
decreased [11–15], or unchanged [6] Sp1 activity. Glycosylation
through theO-linkage of monosaccharide, N-acetylglucosamine
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the condition of glucose starvation, activation of adenylate
cyclase deglycosylates Sp1 protein, resulting in a reduced Sp1
activity [18–20]. Hyperglycemia causes Sp1 hyperglycosylation
and an increased expression of Sp1 dependent gene [21].
Hyperglycosylation of Sp1 transactivation domain inhibits its
interaction with other transcription proteins and reduces its
transcriptional capacity [22,23]. Sp1 activities are also regulated
through interaction with other nuclear proteins including p74,
p107 andMyoD, resulting in an inhibition of Sp1 transactivating
activity [24–26]. Retinoblastoma gene product RB stimulates
Sp1-mediated transcription by liberating Sp1 from a negative
regulator, MDM2 [27].
The major mechanism regulating Sp1 activity is through
altering cellular Sp1 protein abundance mediated principally by
Sp1 protein degradation mechanisms. Various stimuli activate
proteases, which cause Sp1 protein degradation resulting in a
reduced Sp1 activity [15,18–20,28,29]. The protease regulating
Sp1 protein degradation and turnover, and the mechanism
mediating the activation of the protease varies considerably
with cell types and stimuli [15,18–20,28,29]. In rat pituitary
adenoma cells, epidermal growth factor and okadaic acid cause
Sp1 degradation by activating a leupeptin-sensitive cysteine
protease [15], whereas in rat kidney cells, glucose starvation and
adenylate cyclase activation stimulate Sp1 proteolysis through
26S proteasome mechanism [18–20]. In mouse and human T
cells, EL-4 and jurkat cells, retinoid promotes Sp1 proteolysis
by activating caspase [28]. Sp1 protein is spontaneously
degraded by a cathepsin-like protease in unstimulated green
monkey kidney cell line, CV-1 cells [29].
To elucidate the role of Sp1 in LPS signaling, we have been
studying the regulatory effects of LPS on Sp1 DNA-binding
activity [30,31]. We demonstrated that challenge of mice and
rats with LPS in vivo down-regulates Sp1 DNA-binding activity
[30,31], which is accompanied by the down-regulation of two
important Sp1-dependent housekeeping genes [31]. We further
demonstrated that LPS down-regulates Sp1 activity by promot-
ing Sp1 protein degradation [31]. However, the protease
responsible for the LPS-induced Sp1 degradation has not been
identified. In this study, we have identified, characterized and
partially purified an LPS-inducible Sp1-degrading enzyme
(LISPDE) activity that selectively degrades Sp1 protein in the
rat lungs. Our data demonstrated that the LISPDE is a unique
trypsin-like serine protease.
2. Materials and methods
2.1. Materials
N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal (LLnL), clasto-lactacystin-β-
lactone (LTC), hexokinase, D-glucose, 5′-adenylylimino-diphosphate (AMP-
PNP), methylated ubiquitin (MetUb), aprotinin, N-Tosyl-L-phenylalanine
chloromethyl ketone (TPCK), soybean trypsin inhibitor (SBTI), trans-
epoxysuccinyl-L-leucylamido-(4-guanidino) butane (E-64), N-acetyl-Leu-Leu-
Met-al (ALLM), pepstatin A, dansyl-pepstatin, EDTA, 10-phenanthroline
(PATL), leupeptin, phenylmethylsulfonyl fluoride (PMSF), N-t-Boc-Gln-Ala-
Arg-AMC and 7-amino-4-methylcoumarin (AMC) were purchased from Sigma.
Ac-VAD-CHO, Z-Phe-Gly-NHO-Bz-pMe, Z-Arg-Arg-AMC, Suc-Leu-Tyr-
AMC, MeOSuc-Ala-Ala-Pro-Val-AMC, Suc-Ala-Ala-Pro-Phen-AMC werepurchased from Calbiochem. Z-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-βNA and
FA-Gly-Leu-NH2 were purchased from Bachem Americas. Human recombinant
TNF-α was purchased from R&D system. [35S]-L-methionine was purchased
from Amersham Pharmacia Biotech. Monoclonal antibody to C-fos was
purchased from Oncogene. Polyclonal antibodies to Sp1, p50, p65, I-κBα,
actin and monoclonal antibody to human I-κBα were purchased from Santa
Cruz. All other chemicals were of analytical grade and from Sigma.
2.2. Animal protocol
The institutional Animal Care and Use Committee have approved the animal
protocols. Adult Sprague-Dawley rats (350 g) in control and LPS groups were
injected with saline (1 ml/kg, i.p.) or Samonella enteritidis lipopolysaccharide
(LPS, 10 mg/kg, i.p.), respectively. At 10, 60 and 120 min after LPS injection or
120 min after saline injection, animals were killed by exsanguination. Lungs
were removed, snap-frozen and used for extracting cytoplasmic and nuclear
proteins.
2.3. In vitro mixing and degradation assay
Nuclear and cytoplasmic proteins were extracted as we have previously
described [32], omitting the use of protease inhibitors. Contamination of nuclear
and cytoplasmic fractions by cytoplasmic and nuclear proteins, respectively, was
determined by Western analysis using LDH and histone 2A as specific markers.
To identify the LISPDE activity, we performed in vitro mixing and degradation
assay using nuclear protein from control lungs (NP-con) as a substrate, and
nuclear protein from lungs challenged with LPS for 10 (NP-10), 60 (NP-60) and
120 (NP-120) min, respectively, as enzymes. We mixed 5 μg NP-con with10 μg
NP-10, 10 μg NP-60 or 10 μg NP-120 and incubated in reaction buffer (50 mM
Tris–Cl, pH 7.6, 5 mM MgCl2, 2 mM DTT) at RT (∼22 °C) for 1 h. The
reactions were stopped and subjected to Western blot using anti-Sp1 antibody.
Sp1 band intensity in the mixing reactions was compared with that in reactions
containing NP-con, NP-10, NP-60 and NP-120 alone. In the dose response
study, 5 μg NP-con was mixed with 1, 2, 4, 8, 15 and 25 μg NP-120 and
incubated for 1 h before proceeding for Western blot. In the time course study,
5 μg NP-con was mixed with 10 μg NP-120 and incubated for 5, 10, 15, 30, 60
and 120 min, respectively, and subjected to Western blot. In the CP-to-NP cross-
mixing degradation assay, NP-con was used as substrate and cytoplasmic protein
from lungs challenged with LPS for 10 (CP-10), 60 (CP-60) and 120 (CP-120)
min, respectively, were used as enzymes. Reaction condition and groups were
essentially the same as the NP-to-NP mixing reactions with exception of NP-10,
NP-60 and NP-120 being replaced with CP-10, CP-60 and CP-120.
2.4. Western blot analysis
The total reaction volume from each mixing degradation reaction or 20 μg
cytoplasmic proteins from Hela cells were separated on 10% SDS-PAGE under
denaturing conditions. Western blot was performed using antibodies against
Sp1, C-fos, I-κBα, p65, LDH, histone 2A and actin as we have previously
described [30].
2.5. Role of ubiquitin proteasome in LPS-induced Sp1 degradation
To examine the role of 26S proteasome in LPS-induced Sp1 degradation, we
examined the effects of two putative 26S proteasome inhibitors, LLnL and LTC,
of inhibiting ATP hydrolysis and of inhibiting protein ubiquitination on NP-120
induced Sp1 degradation. NP-con (5 μg) was mixed and incubated with 10 μg
NP-10 or 10 μg NP-120 at 37 °C (4 °C for 4 °C group or 80 °C for 80 °C group)
in reaction buffer for 40 min, terminated and subjected to Western blot. In some
of the mixing reactions, NP-120 was pre-incubated with 50 μM or 330 μM
LLnL, 50 μM or 330 μM LTC, an ATP-depleting system (0.5 μg hexokinase+
10 mM D-glucose), 10 mM AMP-PNP (to inhibit ATP hydrolysis) and 10 μg/μl
methylated ubiquitin (to inhibit protein ubiquitination) at 30 °C for 0.5 h before
5 μg NP-con was mixed and incubated at 37 °C for further 40 min.
The effectiveness of LTC in inhibiting ubiquitin proteasome activity was
confirmed by its ability to block TNF-α induced I-κBα degradation in cultured
Hela cells, which is a classic ubiquitin proteasome mediated response [33].
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We determined the mechanistic class of LISPDE activity by employing the
“inhibitor profile” based classification approach [34]. NP-con (5 μg) was mixed
and incubated with 10 μg NP-120 in reaction buffer at RT for 1 h, terminated and
subjected to Western blot. In some of the reactions, NP-120 was pre-incubated
with various protease inhibitors at 30 °C for 60 min before mixing with NP-con
in the mixing degradation reactions. These protease inhibitors are: serine
protease inhibitor, 5 μM aprotinin, 100 μM TPCK and 1.25–20 μM soybean
trypsin inhibitor; cysteine protease inhibitor, 10 μM E-64 and 100 μM ALLM;
aspartic protease inhibitor, 2 μM pepstatin A and 2 μM dansyl-pepstatin;
metalloprotease inhibitor, 4 mM EDTA and 4 mM 10-phenanthroline; and
serine/cysteine protease inhibitor, 0.5–1 mM PMSF and 100 μM leupeptin;
1 μM Ac-VAD-CHO (inhibitor of 8 caspase isoenzymes); and 150 μM Z-Phe-
Gly-NHO-Bz-pMe (selective inhibitor of cathepsin B, L and S). The
concentration of these inhibitors was determined based on their Ki value, if
the Ki was available. Otherwise, we used the highest effective concentration for
those inhibitors that their Ki is not available [34].
2.7. Cleavage of synthetic peptides by LISPDE activity
To further characterize the nature of LISPDE activity, we examined the ability
of NP-120 to cleave 7 fuorogenic peptide substrates with well-defined specificity
(see Table 1). Peptide substrate (200 μM) was mixed with 10 μg NP-120 in
reaction buffer and incubated at RT. The rate of AMC (7-amino-4-methyl-
coumarin) production was monitored for 30 min fluorometrically using
spectrofluorophotometer (Shimadzu) at excitation of 380 nm (490 nm for FA
and 340 nM for NA), and emission of 460 nm (520 nm for FA and 420 nM for
NA).
2.8. DNA constructs and in vitro translation
Human Sp1 cDNA encoding amino acids 1–778 (kindly provided by Dr.
James Kadonaga at UCSD) was subcloned into pGEM vector (Sp1–778). DNA
constructs encoding Sp161–778 (aa 161–778), Sp329–778 (aa 329–778),
Sp480–778 (aa 480–778), Sp650–778 (aa 650–778) and Sp1–180 (aa 1–180)
were generated by restriction enzyme digestion and subcloned into pGEM
vector. These DNA constructs were in vitro transcribed and translated into [35S]-
labeled Sp1 proteins using the TNT Quick Coupled Transcription and
Translation system (Promega) in the presence of [35S]-methionine. To map the
region in Sp1 protein targeting its initial degradation by LISPDE activity, the in
vitro translated Sp1 proteins were mixed with 10 μg NP-120 and incubated in
reaction buffer at RT for 1 h. The reactions were stopped and separated on SDS-
PAGE gel, which was vacuum-dried and subjected to autoradiography.
2.9. Purification of LISPDE protein by affinity chromatography
All procedures were performed at 4 °C. NP-120 (2–8 mg for one typical
experiment) was mixed with 5 ml SBTI–sepharose suspension in 50 mM Tris–
HCl, pH 7.5 and incubated with rotation over night. The mixture was
centrifuged, supernatant collected, and LISPDE activity in the supernatant
measured to determine binding efficiency. The solid phase was resuspended in
the same Tris–HCl buffer, and poured into a BioRad Econo-column (0.7 cm,Table 1
LISPDE activity toward synthetic peptide substrates
Substrates Protease class
N-t-Boc-Gln-Ala-Arg-AMC Serine, trypsin
Suc-Ala-Ala-Pro-Phen-AMC Serine, chymotrpsin
MeOSuc-Ala-Ala-Pro-Val-AMC Serine, elastase,
Z-Arg-Arg-AMC (-NMec) Cysteine, cathepsin B
Suc-Leu-Tyr-AMC Cysteine, calpain
Z-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-βNA Aspartic, rennin
FA-Gly-Leu-NH2 Metallo, thermolysin
Notice: relative activity represents activity relative to the activity toward N-t-Boc-G15 cm), which was washed with 50 mMTris–HCl, pH 7.5 at 0.5 ml/min until the
absorption at A280 fell below 0.01. Following further washing of the column
with 50 mM Tris–HCl (pH 7.5) containing 200 mM NaCl, bound LISPDE
protein was eluted by decreasing column pH to 2.3, which was achieved by
initially pumping 1 mM HCl (pH 3.3) and then 200 mM KCl (pH 2.3) through
the column. The eluted fractions (1 ml) were immediately neutralized by adding
12 μl of 1 M Tris buffer, and assayed for LISPDE activity fluorometrically using
peptide, N-t-Boc-Gln-Ala-Arg-AMC, as substrate. Active fractions were pooled
and concentrated using Amicon filtration unit with an YM-10 membrane
(molecular cutoff, 10,000).
2.10. In gel LISPDE activity assay
Affinity chromatography purified and Amicon concentrated LISPDE
preparation (20 μl) was resolved on 10% SDS-PAGE under non-reducing
condition. After electrophoresis, the gel was washed twice with 4 gel volumes of
washing buffer (50 mM Tris–HCl, pH 7.5, 100 mM NaCl) containing 2.5%
Triton X-100 for 30 min, and twice with washing buffer alone for 10 min.
LISPDE activity was visualized by incubating the gel in washing buffer
containing 200 μM N-t-Boc-Gln-Ala-Arg-AMC at RT for 10 min and
subsequent exposure to UV light.
3. Results
3.1. LPS induces a protease activity that selectively degrades
Sp1
To identify the protease responsible for the LPS-induced Sp1
degradation, we carried out in vitro mixing and degradation
assay. Sp1 protein in NP-10 is not degraded, indicating that
NP-10 does not contain LISPDE activity. Therefore, NP-10 was
used as negative control. Data from our preliminary study
shows that LPS challenged rat and mouse lungs contain similar
LISPDE activity, we used rat lungs to perform all the
experiments in this study. The rat lung gave us a larger supply
of nuclear protein preparation and reduced the number of
animals to be sacrificed. We performed Western blot using NPs
from reactions containing NP-con, NP-10, NP-60 and NP-120
alone and reactions in which NP-con was mixed and incubated
with NP-10, NP-60 or NP-120. While NP-10 alone showed a
similar Sp1 band intensity as compared with NP-con alone (Fig.
1A, Sp1, Ncon, N10), the Sp1 band vanished in NP-60 and
NP-120 alone reactions (Fig. 1A, Sp1, N60, N120), indicating a
complete Sp1 degradation. Mixing of NP-con with NP-10
slightly increased the Sp1 band intensity as expected (Fig. 1A,
Sp1, Ncon+N10). By contrast, incubation of NP-con with
NP-60 or NP-120 significantly reduced the Sp1 band intensity
as compared with NP-con alone, indicating degradation of Sp1Specific activity (FU/min/10 μg) Relative activity (%)
3.114 100
0.331 10
0.047 1
0.068 2
N.D. N.D.
N.D. N.D.
N.D. N.D.
ln-Ala-Arg-AMC. N.D., not detectable.
Fig. 1. LPS induces an LPS-inducible Sp1 degrading enzyme (LISPDE) activity.
(A) LISPDE activity in nuclear extracts. Sp1: nuclear protein (NP) from control
lungs (Ncon, 5 μg) was mixed with NPs (10 μg) from lungs challenged with LPS
for 10 (N10), 60 (N60) and 120 (N120) min respectively, and incubated at RT
for 1 h. Total reaction volume from these mixing reactions and reactions
containing Ncon, N10, N60 or N120 alone was loaded for Western blot using
Sp1-specific antibody. C-fos: membrane for Sp1 blotting was re-blotted with
anti-C-fos antibody. Actin: membrane for Sp1 blotting was re-blotted with anti-
actin antibody. Staining: Fast Green dye staining of the membrane for Sp1
blotting, which showed equal amount of protein in each lane (lanes 1–4, 5 μg/
lane and lanes 5–7, 15 μg/lane). (B) LISPDE activity in cytoplasmic extracts.
Sp1: Ncon (5 μg) was mixed with 10 μg cytoplasmic proteins from lungs
challenged with LPS for 10 (C10), 60 (C60) and 120 (C120) min, respectively,
and incubated at RT for 1 h. The total reaction volume from Ncon, C10, C60 and
C120 alone reactions and from mixing reactions (Ncon+C10, Ncon+C60 and
Ncon+C120) was loaded for Western blot using Sp1-specific antibody. Actin:
membrane for Sp1 blotting was re-blotted with anti-actin antibody.
Fig. 2. LISPDE activity degrades Sp1 protein in a concentration- and time-
dependent manner. (A) NP-con (Ncon, 5 μg) was mixed and incubated with
10 μg NP-120 (N120) at RT for indicated periods of time (min) and subjected to
Western blot using Sp1-specific antibody. (B) NP-con (Ncon, 5 μg) was mixed
with 1, 2, 4, 8, 15 or 25 μg of NP-120 (N120) and incubated at RT for 1 h before
proceeding for Western blot. Actin: membranes of panels A and B were re-
blotted to anti-actin antibody.
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Ncon+N120). These results indicate that NPs from lungs
challenged with LPS for 60 and 120 min, respectively, contains
a LISPDE activity. NP-120 caused a significantly greater Sp1
degradation as compared to NP-60, indicating that the induction
of LISPDE activity is time-dependent. NP-60 or NP-120 did not
cause the degradation of AP-1 family of nuclear protein, C-fos
(Fig. 1A, C-fos), structural protein, actin (Fig. 1A, actin), and
NF-κB family of protein, p65 and I-κBα (data not shown).
These data indicate the selectivity of LISPDE activity towards
Sp1 protein.
Incubation of NP-con with CP-60 or CP-120 also reduced
the Sp1 band intensity as compared with NP-con alone (Fig.
1B), but to a lesser extent, indicating that cytoplasmic protein
also contain LISPDE activity (see later discussion).
3.2. LISPDE activity degrades Sp1 protein in a time- and
dose-dependent manner
We next examined the time and dose dependency of Sp1
degradation by LISPDE activity. We mixed 5 μg NP-con with10 μg NP-120 and incubated at RT for 5, 10, 15, 30, 60 and
120 min, respectively, and performed Western blot. Sp1 band
intensity was significantly reduced in mixing reaction incubated
for 5 min (Fig. 2A, 5 min) compared with NP-con alone (Fig.
2A, Ncon), indicating a significant Sp1 degradation following
5-min incubation. Sp1 band intensity further decreased with the
increasing time of incubation (Fig. 2A). In mixing reactions
incubated for 30 min or longer, Sp1 band vanished (Fig. 2A),
indicating complete degradation. To examine the dose depen-
dency, we mixed 5 μg NP-con with 1, 2, 4, 8, 15 and 25 μg
NP-120, incubated at RT for 60 min and performed Western
blot. A reduced Sp1 band intensity was initially observed in the
reaction that 5 μg NP-con was mixed with 4 μg NP-120 (Fig.
2B). The Sp1 band intensity decreased progressively with the
increasing concentration of NP-120 (Fig. 2B). These results
demonstrated that LISPDE activity degrades Sp1 protein in a
time- and concentration-dependent manner.
3.3. The LISPDE activity is not a 26S proteasome enzyme
activity
Most short-lived signal proteins are degraded by the
ubiquitin proteasome system. Sp1 is known to be degraded
by proteasome system in rat kidney cells [18–20]. To verify
whether the LISPDE activity is an ubiquitin proteasome
activity, we examined the effects of two putative 26S
proteasome inhibitors, LLnL and LTC, on NP-120 induced
Sp1 degradation. LLnL and LTC (both at 50 μM) had no effect
on NP-120 induced Sp1 degradation (Fig. 3A), although
50 μM LTC significantly inhibited TNF-α-induced I-κBα
degradation in cultured Hela cells (Fig. 3C), which is a classic
26S proteasome-mediated response [33]. LLnL was not tested
on cultured cells, since it is not cell membrane permeable.
Higher concentration LTC and LLnL (330 μM) partially
blocked NP-120 induced Sp1 degradation, but a significant
part of this inhibition was due to the effect of high con-
centration of DMSO (6%), solvent for LLnL and LTC (Fig.
Fig. 3. Effects of inhibiting ubiquitin proteasome on LISPDE activity. (A)
Proteasome inhibitors had no effects on LISPDE activity. NP-con (Ncon, 5 μg)
was mixed with 10 μg NP-10 (N10) or NP-120 (N120), incubated at 37 °C for
40 min and the total reaction volume was loaded for Western blot. In some
reactions, NP-120 was pretreated with 50 μM (LLnL50) or 330 μM (LLnL330)
LLnL (a proteasome inhibitor), 50 μM (LTC50) or 330 μM (LTC330) LTC (a
selective proteasome inhibitor), or 6% DMSO (DMSO, solvent for LLnL and
LTC) at 30 °C for 0.5 h, before NP-con was mixed and incubated at 37 °C for
further 40 min. (B) LISPDE activity is not ATP- and ubiquitin-dependent.
NP-con (Ncon, 5 μg) was mixed with NP-120 (N120, 10 μg), incubated at 37 °C
for 40 min and subjected to Western blot. In some reactions, NP-120 was
pretreated with an ATP-depleting system (ATP), 10 mM AMP-PNP (AMP) or
1 μg/μl of methylated ubiquitin (Mub) at 30 °C for 0.5 h, before NP-con was
mixed and incubated at 37 °C for further 40 min. Reaction was incubated at 4 °C
or 80 °C for 4 °C (4 °C) or 80 °C (80 °C) reactions. (C) Clasto-lactacystin-
β-lactone (LTC) blocks TNF-α-induced I-κBα degradation in Hela cells. Hela
cells were unstimulated (Con) or stimulated with 50 ng/ml TNF-α (TNF) or
pretreated with 50 μM LTC for 30 min prior to TNF-α stimulation (TNF/LTC).
Cytoplasmic protein was extracted and subjected to Western blot using antibody
to I-κBα (I-κBα) and actin (actin).
Fig. 4. Effects of various protease inhibitors on the LISPDE activity. Sp1: NP-
con (Ncon, 5 μg) was mixed with NP-120 (N120, 10 μg) and incubated at RT for
1 h. Total reaction volume in NP-con and NP-120 alone reactions and in Ncon+
N120 mixing reactions was loaded for Western blot. In some of the mixing
reactions, NP-120 was pretreated with 10 μM E-64 (E64, cysteine), 100 μM
ALLM (ALLM, cysteine), 150 μM Z-F-G-NHO-bz (CTI, inhibitor of cathepsin
B, L and S), 1 μM Ac-VAD-CHO (CPI, inhibitor of 8 caspase isoenzymes),
0.5% DMSO (DMSO, solvent for ALLM, CTI and CPI), 4 mM EDTA (EDTA,
metallo), 4 mM 10-phenanthroline (PATL, metallo), 2.5 μM or 5 μM soybean
trypsin inhibitor (SBTI, serine), 0.5% methanol (Metn, solvent for PATL), 2 μM
pepstatin A (PeP, aspartic), 2 μM dansyl-pepstatin (Dpep, aspartic), 5 μM
aprotinin (Apro, serine), 0.5% DMSO (DMSO, solvent of pepstatin A, dansyl-
pepstatin), 100 μM TPCK (TPCK, serine, chymotrypsin), 100 μM leupeptin
(Leu, cysteine/serine), 0.5 or 1 mM PMSF (PMSF, serine/cysteine) or 0.5%
ethanol (Ethn, solvent for TPCK and PMSF) at 30 °C for 1 h before mixing with
NP-con in the mixing degradation reactions. Only SBTI and PMSF inhibited
LISPDE activity. Actin: membranes for Sp1 blotting were re-blotted with anti-
actin antibody.
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concentration.
Classic ubiquitin proteasome activity is ubiquitin- and ATP-
dependent, suppressed at low temperature (4 °C) and resistant to
heat [36,37]. To further confirm that LISPDE activity is not
ubiquitin proteasome activity, we tested the effect of eliminating
ATP supply or inhibiting ATP hydrolysis. We employed an
ATP-depleting system [38] to deplete endogenous ATP in the
mixing degradation reactions (Fig. 3B, ATP) or used the non-
hydrolysable ATP analog, AMP-PNP, which competitively
inhibits ATP hydrolysis (Fig. 3B, AMP). We inhibited protein
ubiquitination using methylated ubiquitin (Fig. 3B, Mub),
which competitively inhibits the process of protein ubiquitina-
tion [39]. We performed mixing degradation reactions at low
(4 °C) or high (80 °C) temperature. As illustrated in Fig. 3B,
none of these treatments inhibited NP-120-induced Sp1
degradation, except at 4 °C at which the Sp1 degradation was
slightly inhibited (Figs. 3B, 4C). Thus, the biochemical
characteristics of LISPDE activity do not resemble that of the
classic ubiquitin proteasome enzyme activity. This is consistentwith our demonstration that proteasome activity and LISPDE
activity target different region of Sp1 protein for Sp1 protein
degradation (see Fig. 7).
3.4. Role of caspase and cathepsin-like protease in
LPS-induced Sp1 degradation
Sp1 has been reported to be degraded by caspase in T cell
lines, EL-4 and jurkat cells [28], and by a cathepsin-like
protease in green monkey kidney cell line, CV-1 cells [29]. To
verify whether these two proteases are involved in the LPS-
induced Sp1 degradation, we inhibited the LISPDE activity
with Ac-VAD-CHO (inhibitor of 8 caspase isoenzymes) and
Z-Phe-Gly-NHO-Bz-pMe (a selective inhibitor of cathepsin B,
Fig. 6. Nuclear and cytoplasmic-specific markers in nuclear and cytoplasmic
extracts. The 5 (number 1 to 5) nuclear (NP) and cytoplasmic (CP) extracts listed
in Table 2 were examined for levels of nuclear-specific marker, histone 2A, and
of cytoplasmic-specific marker, LDH, by Western analysis using LDH and
histone 2A-specific antibodies. (A) Histone blotting: high level of histone 2A
was detected in NPs, but not in CPs. (B) LDH blotting: high level of LDH was
detected in CPs, but not in NPs. Note: no cross contamination between nuclear
and cytoplasmic extracts.
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had any effect on the NP-120 induced Sp1 degradation (Fig. 4A,
Sp1, CPI and CTI), indicating that these two proteases are not
involved in the LPS-induced Sp1 degradation.
3.5. LISPDE activity is trypsin-like serine protease activity
We next determined the mechanistic class of LISPDE
activity by employing the “inhibitor profile” based classifica-
tion approach [34]. We pretreated NP-120 with various protease
inhibitors and examined the effects of those inhibitors on
NP-120 induced Sp1 degradation. NP-120 induced Sp1
degradation was not affected by the two cysteine protease
inhibitors, E-64 and ALLM (Fig. 4A, Sp1, E64 and ALLM),
suggesting that LISPDE activity is not a cysteine protease
activity. Similarly, neither the two metalloprotease inhibitors,
EDTA and 10-phenanthroline (Fig. 4B, Sp1, EDTA and PATL),
nor the two aspartic protease inhibitors, pepstatin A and dansyl-
pepstatin (Fig. 4C, Sp1, PeP and DPeP) had an effect on the
NP-120 induced Sp1 degradation, indicating that LISPDE
activity is not a metalloprotease or an aspartic protease activity.
The NP-120 induced Sp1 degradation was not inhibited by
cysteine/serine protease inhibitor, leupeptin (Fig. 4D, Sp1,
Leu), but was significantly inhibited by 0.5 and 1 mM PMSF, a
serine/cysteine protease inhibitor (Figs. 4C and D, Sp1, PMSF).
The serine protease inhibitor, SBTI at 2.5 (Fig. 4D, Sp1, SBTI)
and 5 μM (Fig. 4B, Sp1, SBTI) significantly blocked the NP-
120 induced Sp1 degradation, indicating that the LISPDE
activity is a serine protease activity. Other serine protease
inhibitors, aprotinin (Fig. 4C, Sp1, Apro) and TPCK (Figs. 4B
and D, Sp1, TPCK) failed to block the NP-120 induced Sp1
degradation, suggesting that LISPDE activity is a subclass of
serine protease, trypsin-like protease activity. At the concentra-
tions of 1.25 to 5 μM, SBTI caused a concentration-dependent
inhibition of the NP-120 induced Sp1 degradation (Fig. 5, Sp1).
At concentration higher than 5 μM no further inhibition was
observed (Fig. 5, Sp1), suggesting that maximum inhibition has
achieved. Taken together, these results suggest that the protease
responsible for LPS-induced Sp1 degradation is trypsin-like
serine protease.Fig. 5. SBTI inhibits LISPDE activity in a concentration-dependent manner.
Sp1: NP-con (Ncon, 5 μg) was mixed with NP-120 (N120, 10 μg) and incubated
at RT for 1 h. NPs from Ncon and N120 alone reactions and from Ncon+N120
mixing reactions were subjected to Western blot. In some of the mixing
reactions, NP-120 was pretreated with 1.25, 2.5, 5, 10 and 20 μM soybean
trypsin inhibitor (SBTI) at 30 °C for 1 h before mixing with NP-con in the
mixing degradation reactions. Actin: membrane for Sp1 blotting was re-blotted
with anti-actin antibody.3.6. LISPDE activity selectively cleave peptide substrates for
trypsin
To further confirm that the LISPDE activity is a trypsin-like
protease activity, we examined the ability of NP-120 to cleave 7
fluorogenic peptide substrates with well-defined specificity
(Table 1). We incubated 10 μg NP-120 with these 7 peptide
substrates, and assay for the cleavage release of fluorogen.
NP-120 cleaved the trypsin substrate, N-t-Boc-Gln-Ala-Arg-
AMC with high efficacy, but did not cleave any other peptide
substrate, except a slight cleavage of the chymotrpsin substrate,
further confirming that the LISPDE activity is a trypsin-like
activity (Table 1).
3.7. Nuclear extracts contain higher level of LISPDE activity
To determine the relative subcellular distribution of LISPDE
activity (cytoplasm vs. nucleus), we compared LISPDE activity
in nuclear extracts (NP-60 and NP-120) with that in cytoplasmic
extracts (CP-60 and CP-120) from the same LPS challenged
lungs. The possible cross contamination between nuclear and
cytoplasmic fractions was excluded based on Western analysis,
which showed that nuclear extracts contained high level of, but
cytoplasmic extracts contained little nuclear-specific marker,
histone 2A (Fig. 6A), and that cytoplasmic extracts contained
high level of, but nuclear extracts contained little cytoplasmic-
specific marker, LDH (Fig. 6B). We performed mixing and
cross-mixing degradation reactions using NP-con as substrate
and NP-60 (and NP-120) as enzyme or using NP-con as
substrate and CP-60 (and CP-120) as enzyme. The extent of Sp1
protein degradation in the CP-to-NP mixing reactions was
compared with that in the NP-to-NP mixing reactions. We
reasoned that if LISPDE activity is predominantly localized in
nuclear compartment, NP-to-NP mixing reactions should cause
a significantly greater reduction in Sp1 band intensity compared
with that in CP-to-NP mixing reactions, and visa versa.
Although both NP-to-NP and CP-to-NP mixing reduced the
Sp1 band intensity (Figs. 1A and B, Sp1), incubation of NP-con
Table 2
Comparison of LISPDE activity in nuclear and cytoplasmic extracts
Rat # NP (FU/min/10 μg) CP (FU/min/10 μg) NP/CP activity ratio (fold)
1 1.532 0.217 7.0
2 3.113 0.121 25.7
3 1.423 0.158 9.0
4 4.107 0.322 12.7
5 4.851 0.301 16.1
Activity towards N-t-Boc-Gln-Ala-Arg-AMC was assayed fluorometrically.
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in Sp1 band intensity (compare Fig. 1A, Ncon+N60 and Ncon+
N120 to Fig. 1B Ncon+C60 and Ncon+C120), suggesting that
nuclear extracts contain higher level of LISPDE activity. To
further confirm that LISPDE activity is mainly a nuclear
protease activity, we compared the capability of NP-120 and CP-
120 to cleave the peptide substrate, N-t-Boc-Gln-Ala-Arg-
AMC. Table 2 summarized the N-t-Boc-Gln-Ala-Arg-AMC
cleaving activity of NP-120 and CP-120 from 5 LPS challenged
lungs. On average, the N-t-Boc-Gln-Ala-Arg-AMC cleaving
activity in nuclear extract was 14.1±3.3-fold of that in
cytoplasmic extract. These results further suggest that LISPDE
activity is predominantly a nuclear protease activity.
3.8. Mapping of the initial cleavage site in Sp1 for its
degradation by LISPDE activity
To map the region containing the target domain for Sp1
degradation by LISPDE activity, we made a series of DNA
constructs encoding various lengths of Sp1 peptides. We named
them as Sp1–778 (aa 1–778), Sp161–778 (aa 161–778),
Sp329–778 (aa 329–778), Sp480–778 (aa 480–778), Sp650–
778 (aa 650–778) and Sp1–180 (aa 1–180). Sp1 fragments
translated from these DNAs were used as substrates in the
mixing and degradation reaction using NP-120 as protease. As
shown in Fig. 7, Sp1–778 and Sp161–778 were completely
degraded by NP-120 (Fig. 7, Sp1–778 and Sp161–778). While
Sp329–778 was slightly degraded (Fig. 7, Sp329–778),
Sp480–778 (Fig. 7, Sp480–778) and Sp650–778 (data notFig. 7. Region between amino acids 181–328 contains the initial cleave site targeti
amino acids 1–778 (Sp1–778), 161–778 (Sp161–778), 329–778 (Sp329–778), 480–
and translated into [35S]-labeled Sp1 protein or protein fragments. The [35S]-labeled
buffer plus 10 μg NP-120 (N120) at RT for 1 h, and subjected to SDS-PAGE. Theshown) were not cleaved at all by NP-120. Because fragment
Sp1–180 (Fig. 7, Sp1–180) was not cleaved by NP-120, these
results mapped the initial cleaving site that target Sp1 protein
degradation by LISPDE activity within the region between
amino acids 181 to 328. The domain targeting initial Sp1
degradation by 26S proteasome system is located between
amino acids 1 to 54 [19]. These results further confirm that
LISPDE activity is not a 26S proteasome activity.
3.9. Partially purified LISPDE preparation selectively
degrades Sp1 protein
To further characterize LISEDE activity, we have partially
purified LISEDE protein from NP-120 using affinity chromato-
graphy. Fig. 8 shows chromatography profile of LISPDE on
SBTI–sepharose affinity column in one typical experiment. A
total of 2.4 mg NP-120 (total LISPDE activity, 218 fluorescence
units [FU]) was mixed with 5 ml SBTI–sepharose and loaded
into column. Unbound proteins remained in the supernatant or
were eluted into fractions 1 to 10. Approximately 55% of the
loaded LISPDE activity bound to the SBTI–sepharose resin,
and 25% of the bound LISPDE activity was eluted into fractions
54 to 59, which coincided with the second protein peak as
measured by A280 absorbance (Fig. 8). A total of 30 FU of
LISPDE activities were eluted, which represents a 25%
recovery. Because of the low recovery from affinity column,
active fractions (total, 30 fractions) from 5 purifications were
pooled and concentrated from 30 ml to a volume of 200 μl using
Amicon filtration unit. Recovery from the concentration
procedure is approximately 16%.
We next examined the specificity of the partially purified
LISPDE preparation using native Sp1 protein as substrate. Fig.
9A shows electrophoretic analysis of 20 μl of the affinity
column purified and Amicon concentrated LISPDE preparation
(the protein concentration was too low to be quantified). In gel
protease activity assay using N-t-Boc-Gln-Ala-Arg-AMC as
substrate showed single band with estimated molecular mass of
33 kDa (Fig. 9A). Silver staining of the gel showed that in
addition to the 33-kDa LISPDE band (Fig. 9B, arrow indicated),ng Sp1 degradation by LISPDE activity. DNA constructs (in pGEM) encoding
778 (Sp480–778) and 1–180 (Sp1–180) were generated and in vitro transcribed
Sp1 proteins were mixed and incubated with reaction buffer alone (Con) or with
gel was vacuum-dried and underwent autoradiography.
Fig. 9. Partially purified LISPDE selectively degrades native Sp1 protein. (A and B) E
column purified and Amicon concentrated preparation was resolved on 10% SDS-PA
quantified). The gel was washed with washing buffer containing 2.5% Triton X-100
Materials and methods section. LISPDEwas visualized and photographed under UV l
shows a single band with estimated molecular mass of 33 kDa. (B) Silver staining sh
least 4 other protein bands (weak bands), indicating that affinity column purified p
LISPDE preparation selectively degrades Sp1 protein. Sp1: Nuclear protein from con
(Ncon+LSE4) of the purified and concentrated LISPDE preparation at RT for 30 m
Western blot using Sp1-specific antibody. C-fos: membrane for Sp1 blotting was re-b
with anti-actin antibody.
Fig. 8. Chromatography profile of LISPDE on SBTI–sepharose affinity column.
NP-120 (2.4 mg) was incubated with SBTI–sepharose over night, loaded into a
BioRad Econo-column (0.7 cm, 15 cm). The first protein peak (fractions 1–10)
eluted by 50 mM Tris–HCl (pH 7.5) represents unbound proteins and contains
low LISPDE activity. The second protein peak (fractions 54–59) eluted by
decreasing column pH to 2.3 contains higher LISPDE activity. Protein was
monitored by absorbance at 280 (●) and LISPDE activity was measured by
monitoring the hydrolysis of N-t-Boc-Gln-Ala-Arg-AMC (▴). Fractions 54 to
59 together with active fractions collected from other 4 purifications (total, 30
fractions in 30 ml) were pooled and concentrated with Amicon filtration unit to
200 μl for further analysis.
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indicating that the affinity column purified preparation is
partially purified LISPDE preparation. To examine the
capability and selectivity of the partially purified LISPDE in
degrading native Sp1 protein, we mixed and incubated the
LISPDE preparation with 5 μg NP-con, and proceeded for
Western blot. Incubation of NP-con with 2 μl of the purified
LISPDE preparation significantly reduced the Sp1 band
intensity (Fig. 9C, Sp1, Ncon+LSE2), and incubation with
4 μl of the purified preparation completely abolished the Sp1
band (Fig. 9C, Sp1, Ncon+LSE2). Re-blotting of the same
membrane to antibodies against C-fos and actin showed that the
purified LISPDE preparation had no proteolytic action on AP-1
family of protein, C-fos and structural protein actin (Fig. 9C,
C-fos and actin), demonstrating the selectivity of the partially
purified LISPDE on Sp1 protein. These results confirm the
partial purification of LISPDE protein.
4. Discussion
We have previously demonstrated that challenge of rat and
mice with LPS in vivo down-regulates Sp1 binding activity and
promotes Sp1 protein degradation. Here, we have identified,
characterized and partially purified the protease activity that is
responsible for the LPS-induced Sp1 degradation. Using an inlectrophoretic analysis of purified LISPDE preparation. Twenty μl of the affinity
GE under non-reducing condition (the protein concentration was too low to be
to remove SDS, and incubated with N-t-Boc-Gln-Ala-Arg-AMC as described in
ight, and the gel was subjected to silver staining. (A) Protease activity in gel assay
ows that in addition to the 33-kDa LISPDE band (arrow indicated), there were at
reparation is partially purified LISPDE preparation. (C) The partially purified
trol lungs (Ncon, 5 μg) was mixed and incubated with 2 μl (Ncon+LSE2) or 4 μl
in. The mixing reactions were resolved on 10% SDS-PAGE and subjected to
lotted with anti-C-fos antibody. Actin: membrane for Sp1 blotting was re-blotted
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induced a protease activity, which caused Sp1 protein
degradation in a time- and concentration-dependent manner.
The protease activity is selective for Sp1, because it did not
degrade nuclear proteins, c-fos, p65, I-κα and structural protein,
actin. This protease activity was detected in NP-60 and NP-120,
but not in NP10. NP-120 contains a significantly higher
protease activity than that in NP-60, indicating that the protease
activity is LPS-inducible and that the induction of this protease
activity is time-dependent. The time course of the induction of
the protease activity by LPS correlates well with the time
courses of LPS-induced Sp1 protein degradation, down-
regulation of Sp1 binding activity, and down-regulation of
Sp1-mediated transcription of housekeeping genes as we have
demonstrated in our previous studies [30], indicating the
biological significance of this LPS-induced protease activity.
We named this protease activity as LPS-inducible Sp1-
degrading enzyme (LISPDE) activity. Thus, we have demon-
strated that LPS challenge in vivo induces a unique LISPDE
activity that causes Sp1 protein degradation.
We showed that the NP-con+NP120 mixing reactions
caused a significantly greater reduction in Sp1 band intensity
compared with NP-con+CP120 mixing reactions, and that
nuclear extract contained 14-fold of N-t-Boc-Gln-Ala-Arg-
AMC cleaving activity as that detected in cytoplasmic extract
from the same group of lungs. These results suggest that
LISPDE activity is predominantly localized in nucleus. Because
the nuclear and cytoplasmic extracts were made using different
extracting buffer, an alternative explanation is that nuclear
extraction buffer was more effective than cytoplasmic extrac-
tion buffer in extracting LISPDE protein from tissues. However,
the protein concentration in nuclear extracts is significantly
lower than that in cytoplasmic extracts, suggesting that this
possibility is unlikely. We did not pursue this issue further for
two reasons. First, it would be difficult to completely avoid
cross contamination between subcellular fractions. Secondly,
cellular and subcellular localization of LISPDE protein can be
easily determined by immunohistochemical staining of tissue
section. We will be able to re-examine this issue when we have
obtained the LISPDE protein sequence and generated anti-
LISPDE antibody.
Depending on cell types and stimuli, Sp1 has been reported
to be degraded by multiple proteases, including 26S proteasome
proteases [18–20], caspase [28], a cathepsin-like protease [29]
and a leupeptin-sensitive cysteine protease [15]. In searching for
the nature of LISPDE activity, we at first attempted to verify
whether LISPDE activity is any of these reported protease
activity. To clarify whether LISPDE activity is an ubiquitin
proteasome system enzyme activity, we tested the effects of two
putative 26S proteasome inhibitors, compared the biochemical
characteristics between LISPDE and 26S proteasome activities,
and mapped the region containing the targeting domain for Sp1
degradation by the LISPDE activity. LLnL and LTC (both at
50 μM) had no effect on LISPDE activity, although 50 μM LTC
significantly inhibited TNF-α-induced I-κBα degradation in
cultured Hela cells, which is a classic 26S proteasome-mediated
response [33]. Others have reported that 20 μMLTC and 50 μMLLnL completely inhibited 26S proteosome-mediated Sp1
degradation [18,19]. LLnL at 50–100 μM maximally inhibits
the degradation of several proteasome degradable proteins or
synthesized peptides [35]. The inhibition by high concentration
of LTC and LLnL (330 μM) is likely to be a combined effect of
high concentration of DMSO (6%) and non-specific effects of
the inhibitors. The biochemical characteristics of LISPDE
activity did not resemble that of the classic ubiquitin proteasome
activity. Classic ubiquitin proteasome activity is ubiquitin- and
ATP-dependent, whereas the LISPDE activity is neither
ubiquitin- nor ATP-dependent. Moreover, the LISPDE activity
and the 26S proteasome activity degrade Sp1 protein by
targeting different initial cleaving sites. The domain targeting
Sp1 protein degradation by LISPDE activity was located
between amino acids 181 to 328, whereas the domain targeting
Sp1 protein degradation by proteasome was located between
amino acids 1 to 54 [19]. Sp1 fragments lacking amino acids 1–
54 are resistant to 26S proteasome degradation [19]. In contrast,
Sp1 fragment lacking amino acids 1–54 (Sp161–778) was
completely degraded by LISPDE activity. Sp1 fragment
containing amino acids 1–54 (Sp1–180), was resistant to
degradation by the LISPDE activity. In addition, LISPDE is a
small molecule protease with an estimated molecular mass of
33 kDa. This is in sharp contrast with 26S proteasome which is
a large molecular size protease complex. Taken together, our
results demonstrated that LISPDE activity is not a classic
ubiquitin proteasome activity.
Cathepsin-like protease degrades Sp1 protein in unstimulated
CV-1 cells [29]. We did not detect any LISPDE activity in
control lungs. The reported cathepsin-like protease is cathepsin
B-like cysteinyl protease, and its activity is completely blocked
by E-64 and other cysteine protease inhibitors [29]. In contrast,
LISPDE activity is a serine protease activity (see later
discussion), and is not affected by any cysteine protease
inhibitor, including E-64. Moreover, we demonstrated that
LISPDE activity did not cleave the peptide substrate specific for
cathepsin B and that the selective inhibitor for cathepsin B, L and
S, Z-Phe-Gly-NHO-Bz-pMe, had no effect on LISPDE activity.
Degradation of Sp1 protein by caspase occurs in apoptotic, but
not in control cells [28]. Apoptosis is not detectable, and caspase
activity, as determined using caspase assay kit, is not elevated
until 6 h post-LPS challenge in mouse lungs [40]. We showed
that LISPDE activity elevated significantly at 1 h andmaximized
at 2 to 3 h post-LPS. Additionally, Ac-VAD-CHO, a potent
inhibitor of 8 caspase isoenzymes, had no effect on the NP-120
induced Sp1 degradation. Collectively, these results indicate that
LISPDE activity is very unlikely to be caspase and cathepsin-
like protease activity.
Based on chemical nature of the catalytic site, proteases can
be grouped into 4 mechanistic classes: serine proteases, cysteine
proteases, metalloproteases, and aspartic proteases. Proteases in
each class are inhibited by their specific inhibitors. We
determined the mechanistic class of LISPDE activity based on
the “inhibitor profile” [34]. We tested at least 2 highly selective
inhibitors of each of the 4 classes of protease. Of these inhibitors
tested, only the serine protease inhibitor, SBTI, and the serine/
cysteine protease inhibitor, PMSF, blocked or significantly
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LISPDE activity is a serine protease activity. This conclusion is
supported by our observation that NP-120 cleaved serine
protease substrate with high efficacy, but had no or little
cleaving activity towards other substrates. Not all serine
protease inhibitors inhibited LISPDE activity. Serine protease
inhibitors, TPCK and aprotinin, failed to inhibit NP-120
induced Sp1 degradation, whereas SBTI inhibited NP-120
induced Sp1 degradation in a concentration-dependent manner,
suggesting that the LISPDE activity is a subclass of serine
protease. This is consistent with our demonstration that NP-120
cleaved the trypsin substrate (N-t-Boc-Gln-Ala-Arg-AMC) with
high efficacy, but had little cleaving activity towards the
chymotrypsin substrate (Suc-Ala-Ala-Pro-Phen-AMC). Thus,
both inhibitor profile and substrate preference studies indicate
that LISPDE activity is a trypsin-like protease activity. LISPDE
activity is predominantly localized in nucleus, as nuclear extract
contains 14-fold of LISPDE activity as that detected in
cytoplasmic extract. The purified LISPDE is a 33-kDa protein
as estimated on SDS-PAGE and displays the same functional
characteristics and substrate specificity as that of NP-20.
Sp1 fragment lacking amino acids 181–328 is resistant to
LISPDE degradation, suggesting that initial proteolytic clea-
vage site by LISPDE activity is located within this region. An
alternative explanation is that the initial cleaving site is located
within other region, but the region between amino acids 181 and
328 is important for the proper folding of Sp1 protein that is
necessary for Sp1 and LISPDE interaction. Deletion of this
region prevents the interaction and Sp1 degradation by LISPDE
activity. However, all other Sp1 fragments tested are resistant to
LISPDE degradation. Nevertheless, region between amino
acids 181 and 328 is important for Sp1 protein degradation by
LISPDE activity. Future site-directed mutagenesis experiment
using Sp1–778 as template will clarify this question.
Sp1 was detected as doublet band on Western blots in some
experiments. We believe that the lower band (smaller size)
represents serine or threonine dephosphorylated Sp1 protein.
Because we have previously demonstrated that the depho-
sphorylated Sp1 protein lost its DNA-binding capacity in LPS
challenged lungs [30], this study was focused on the upper band
(larger size band).
The biological and pathological significance of the LISPDE-
mediated down-regulation of Sp1 activity remains to be studied.
It is well documented that Sp1 mediates or contributes to the
transcriptional expression of hundreds of housekeeping genes,
the majority of tissue-repairing genes, and multiple anti-
inflammatory genes (for a complete list, refer to PubMed,
using key word Sp1). We have previously demonstrated a
greatly reduced expression of two most important Sp1-depen-
dent housekeeping genes, endothelial nitric oxide synthase and
cyclooxygenase-1, in the same lungs that we observed a down-
regulation of Sp1 activity [30]. It is speculated that down-
regulation of Sp1 activity during endotoxemia could result in a
repressed or diminished expression of these housekeeping,
tissue-repairing, and anti-inflammatory genes, leading to the
disruption of normal organ functions, impairment of tissue-
repairing mechanisms, and suppression of anti-inflammatorymechanisms. All of which would exacerbate the inflammatory
and injurious responses, facilitating the development septic
shock and septic multiple organ injury.
In summary, we have identified, characterized and partially
purified a protease that is responsible for Sp1 protein
degradation in LPS challenged rat lungs. We named the
protease as LPS-inducible Sp1-degrading enzyme (LISPDE).
We showed that LISPDE is LPS inducible and that the induction
of LISPDE activity is time-dependent. The induction of
LISPDE activity temporally correlates with LPS-induced Sp1
protein degradation, down-regulation of Sp1 binding activity,
and down-regulation of Sp1-mediated gene transcription as we
have previously demonstrated [30]. We further demonstrated
that LISPDE activity is not the 26S proteasome activity and the
reported cathepsin-like or caspase activity. LISPDE activity is a
unique trypsin-like protease activity. We mapped the domain
targeting Sp1 protein degradation by LISPDE activity being
located within the region between amino acids 181–328. We
showed that the partially purified LISPDE is a 33 kDa protein as
estimated on SDS-PAGE and displays the same functional
characteristics and substrate specificity as that of NP-20. Thus,
we have demonstrated that challenge of rat with LPS in vivo
induces a unique nuclear trypsin-like serine protease, LISPDE,
that selectively degrades Sp1 protein.
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